Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 605

1.

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Joubert M, Reznik Y.

Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28. Review.

PMID:
22209014
2.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
3.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
4.

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M.

Diabetes Care. 2009 Dec;32(12):2245-50. doi: 10.2337/dc09-0750. Epub 2009 Sep 18.

5.

Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I.

Diabetes Technol Ther. 2011 Nov;13(11):1109-13. doi: 10.1089/dia.2011.0081. Epub 2011 Jul 13.

PMID:
21751889
7.

What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.

Polonsky WH, Hessler D.

Diabetes Technol Ther. 2013 Apr;15(4):295-301. doi: 10.1089/dia.2012.0298. Epub 2013 Feb 21.

PMID:
23427866
8.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
9.

Continuous glucose monitors: current status and future developments.

Lane JE, Shivers JP, Zisser H.

Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):106-11. doi: 10.1097/MED.0b013e32835edb9d. Review.

PMID:
23422244
10.

Quality of life and technology: impact on children and families with diabetes.

Hirose M, Beverly EA, Weinger K.

Curr Diab Rep. 2012 Dec;12(6):711-20. doi: 10.1007/s11892-012-0313-4. Review.

11.

Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.

Wojciechowski P, Ryś P, Lipowska A, Gawęska M, Małecki MT.

Pol Arch Med Wewn. 2011 Oct;121(10):333-43. Review.

13.

Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study.

Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A, Tubiana-Rufi N, Sulmont V, Catargi B, Lukas C, Radermecker RP, Thivolet C, Moreau F, Benhamou PY, Guerci B, Leguerrier AM, Millot L, Sachon C, Charpentier G, Hanaire H; EVADIAC Sensor Study Group.

Diabetes Care. 2012 May;35(5):965-71. doi: 10.2337/dc11-2021. Epub 2012 Mar 28.

14.

Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.

Diabetes Care. 2010 Jan;33(1):17-22. doi: 10.2337/dc09-1502. Epub 2009 Oct 16.

15.

Clinical outcomes associated with referral-based continuous glucose monitoring using a central standardized interpretation strategy.

Miele A, Weiland K, Dungan KM.

Diabetes Technol Ther. 2012 Sep;14(9):765-71. doi: 10.1089/dia.2012.0081.

PMID:
22928614
16.

A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.

Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group.

Diabetes Care. 2012 Feb;35(2):204-10. doi: 10.2337/dc11-1746. Epub 2011 Dec 30.

17.

The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.

Lawson ML, Bradley B, McAssey K, Clarson C, Kirsch SE, Mahmud FH, Curtis JR, Richardson C, Courtney J, Cooper T, Downie CJ, Rajamannar G, Barrowman N; CGM TIME Trial Study Group; JDRF Canadian Clinical Trial Network CCTN1101.

BMC Pediatr. 2014 Jul 18;14:183. doi: 10.1186/1471-2431-14-183.

18.
19.

Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.

Khalil AB, Beshyah SA, Abu Awad SM, Benbarka MM, Haddad M, Al-Hassan D, Kahwatih M, Nagelkerke N.

Diabetes Technol Ther. 2012 Sep;14(9):813-8. doi: 10.1089/dia.2012.0061. Epub 2012 Jul 24.

PMID:
22827507
20.

Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.

Hovorka R, Nodale M, Haidar A, Wilinska ME.

Diabetes Technol Ther. 2013 Jan;15(1):4-12. doi: 10.1089/dia.2012.0185. Epub 2012 Oct 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk